Abattis Bioceuticals Income Statement

Financials in millions CAD. Fiscal year is October - September.

Millions CAD. Fiscal year is Oct - Sep.

Fiscal Year	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Sep '19 Sep 30, 2019	Sep '18 Sep 30, 2018	Sep '17 Sep 30, 2017	Sep '16 Sep 30, 2016	Sep '15 Sep 30, 2015
Revenue	0.36	0.01	-	-	0.09
Revenue Growth (YoY)	4163.24%	-	-	-	1090.93%
Cost of Revenue	0.12	0	-	-	0.03
Gross Profit	0.24	0.01	-	-	0.06
Selling, General & Admin	4.06	15.21	4.6	2.02	2.55
Research & Development	-	0.03	0.01	0.04	0.08
Amortization of Goodwill & Intangibles	-	-	0.07	0.07	0.08
Operating Expenses	4.15	15.78	5.43	2.26	3.06
Operating Income	-3.91	-15.78	-5.43	-2.26	-3
Interest Expense	-0.04	-4.33	-	-0.01	-0.02
Earnings From Equity Investments	-	-0.87	-	-	-
Currency Exchange Gain (Loss)	0.25	-0.02	-0	-0.01	0.01
Other Non Operating Income (Expenses)	0.31	-28.31	0.07	-0.07	-0.24
EBT Excluding Unusual Items	-3.39	-49.31	-5.36	-2.35	-3.25
Merger & Restructuring Charges	-	-11.35	-	-	-
Impairment of Goodwill	-	-10.43	-	-	-0.51
Gain (Loss) on Sale of Investments	0.33	-10.92	-	-0.01	-0.3
Gain (Loss) on Sale of Assets	-	5.07	-	-	-0.39
Asset Writedown	-0.05	-0.04	-0.95	-	-1.83
Other Unusual Items	0.06	-0.68	-0.74	-0.05	0.29
Pretax Income	-3.06	-77.65	-7.05	-2.41	-5.99
Income Tax Expense	-	-	-	-	-0.42
Earnings From Continuing Operations	-3.06	-77.65	-7.05	-2.41	-5.57
Earnings From Discontinued Operations	-	-	-0.88	-	-
Net Income to Company	-3.06	-77.65	-7.93	-2.41	-5.57
Minority Interest in Earnings	0.02	-0.36	0.29	0.07	1.1
Net Income	-3.04	-78.01	-7.63	-2.34	-4.47
Net Income to Common	-3.04	-78.01	-7.63	-2.34	-4.47
Shares Outstanding (Basic)	470	323	149	95	69
Shares Outstanding (Diluted)	470	323	149	95	69
Shares Change (YoY)	45.83%	117.02%	56.50%	38.04%	41.01%
EPS (Basic)	-0.01	-0.24	-0.05	-0.02	-0.06
EPS (Diluted)	-0.01	-0.24	-0.05	-0.02	-0.06
Free Cash Flow	9.35	-8.51	-1.65	-0.78	-1.86
Free Cash Flow Per Share	0.02	-0.03	-0.01	-0.01	-0.03
Gross Margin	67.63%	77.37%	-	-	68.11%
Operating Margin	-1095.65%	-188474.47%	-	-	-3262.40%
Profit Margin	-852.40%	-931940.11%	-	-	-4864.64%
Free Cash Flow Margin	2620.32%	-101698.69%	-	-	-2021.59%
EBITDA	-3.84	-15.74	-5.34	-2.13	-2.82
D&A For EBITDA	0.07	0.04	0.09	0.13	0.18
EBIT	-3.91	-15.78	-5.43	-2.26	-3
Advertising Expenses	1.17	3.14	0.14	0.08	0.13

Source: S&P Global Market Intelligence. Standard template. Financial Sources.